OncLive TV

OncLive® TV is an editorial video program featuring one-on-one live and/or virtual interviews with key opinion leaders in the oncology field for their expert insight on breaking news, regulatory updates, practice-changing data presented at medical meetings, and other pivotal topics in a cancer specialty, including breast cancer, lung cancer, genitourinary cancers, gastrointestinal cancers, gynecologic cancers, and hematologic cancers.

Dr Hayek on Laparoscopic vs Open Surgery in Advanced Ovarian Cancer

March 17th 2024

Judy Hayek, MD, discusses outcomes with minimally invasive vs open interval complete gross resection in patients with advanced ovarian cancer.

Dr Randall on PROs With Pembrolizumab Plus Chemoradiotherapy in Cervical Cancer

March 17th 2024

Leslie M. Randall, MD, MAS, discusses patient-reported outcomes from the ENGOT-cx11/GOG 3047/KEYNOTE-A18 trial in locally advanced cervical cancer.

Dr Nasioudis on the Use of SLNB in Metastatic Vulvar Squamous Cell Carcinoma

March 16th 2024

Dimitrios Nasioudis, MD, discusses outcomes of patients with metastatic vulvar squamous cell carcinoma who underwent sentinel lymph node biopsy.

Dr Corvigno on Chemotherapy-Related Clonal Hematopoiesis in Ovarian Cancer

March 16th 2024

Sara Corvigno, MD, PhD, discusses the incidence of chemotherapy-related clonal hematopoiesis of indeterminate potential in patients with ovarian cancer.

Dr Liu on Surgical Outcomes Following Radiation and Chemotherapy in Rectal Cancer

March 16th 2024

I-Chia (Daniel) Liu, MD, discusses surgical and local control outcomes following short-course radiation therapy and chemotherapy for rectal cancer.

Dr Kenderian on the FDA Approval of Liso-Cel in Relapsed/Refractory CLL/SLL

March 15th 2024

Saad J. Kenderian, MD, CHB, discusses the FDA approval of lisocabtagene maraleucel for chronic lymphocytic leukemia or small lymphocytic lymphoma.

Dr Taplin on Addressing Disparities in Prostate Cancer Care Through Community Engagement

March 15th 2024

Mary-Ellen Taplin, MD, discusses efforts to address disparities in access to, and delivery of, prostate cancer care.

Dr Knight on the Investigation of Patients With Brain-Metastatic Prostate Adenocarcinoma

March 15th 2024

James Knight, MD, discusses the potential launch of a case series of patients with brain-metastatic prostate adenocarcinoma.

Dr Efstathiou on the Role of Tri-Modality Therapy in MIBC

March 15th 2024

Jason Efstathiou, MD, DPhil, discusses the role of tri-modality therapy in patients with muscle-invasive bladder cancer.

Dr Zaha on the Risk of Cardiovascular Toxicity in Patients With Lung Cancer

March 15th 2024

Vlad Gabriel Zaha, MD, PhD, discusses the risk of cardiovascular toxicity in patients with lung cancer undergoing treatment with radiation.

Dr Singh on the Utility of Radiation Therapy in Lung Cancer

March 14th 2024

Raj Singh, MD, discusses radiation therapy in patients with metastatic lung cancer, highlighting the evolution of treatment within this landscape.

Dr Franco on the Integration of Immunotherapy Treatment in Endometrial Cancer

March 14th 2024

Idalid Franco, MD, MPH, discusses the use of radiation therapy and immunomodulatory agents in the treatment of endometrial cancer.

Dr Plichta on Areas of Interest for Genetic Testing Research in Breast Cancer

March 14th 2024

Jennifer K. Plichta, MD, MS, discusses key areas of interest regarding the role and optimization of genetic testing in breast cancer.

Dr Hwang on the Potential Use of Multicancer Early Detection Tests in Breast Cancer Screening

March 14th 2024

Shelley Hwang, MD, MPH, discusses the potential use of multicancer early detection tests in breast cancer screening.

Dr Pellini on the Clinical Utility of ctDNA Assays in NSCLC

March 13th 2024

Bruna Pellini, MD, discusses the utility of circulating tumor DNA assays in non–small cell lung cancer.

Dr Grajales-Cruz on the Safety of Teclistamab in Multiple Myeloma

March 13th 2024

Ariel F. Grajales-Cruz, MD, discusses the real-world efficacy of teclistamab in relapsed/refractory multiple myeloma.

Dr Rini on the FDA Approval of Belzutifan in Relapsed/Refractory RCC

March 13th 2024

Brian I. Rini, MD, FASCO, shares the importance of the FDA approval of belzutifan in patients with advanced renal cell carcinoma.

Dr Pedersen on the Evolving Use of Cytoreductive Surgery for Peritoneal Carcinomatosis

March 13th 2024

Katrina S. Pedersen, MD, MS, discusses the evolving use of cytoreductive surgery for patients with peritoneal carcinomatosis.

Dr Sartor on PSMA PET and Radioligand Therapy in Prostate Cancer

March 13th 2024

Oliver Sartor, MD, discusses the use of PSMA PET and radioligand therapy in prostate cancer.

Dr Jimenez on the Radiation Treatment Paradigm in Breast Cancer

March 13th 2024

Rachel Jimenez, MD, discusses unmet needs in radiation treatment for patients with breast cancer.